<?xml version="1.0" encoding="UTF-8"?>
<p id="par0140">Targeting the SARS-CoV-2 viral RNA genome for degradation may hold a promise, but it is challenging during the current pandemic, considering that viral RNA sequence domains are not known and limited targeted delivery of the oligonucleotide to the lungs may limit the scale-up manufacturing of such drugs for a large population of infected individuals 
 <xref rid="bib0375" ref-type="bibr">[75]</xref>.
</p>
